Sourcebio International (SBI) Share Price, News & Analysis

Company Overview

Sourcebio International Plc, together with its subsidiaries, provides various laboratory services and products to clients in the healthcare, clinical, life science research, and biopharma industries in the United Kingdom, Europe, the United States, and internationally. The company's services cover histopathology cancer screening and clinical diagnostic services; DNA sequencing services and precision medicine to pharmaceutical and biotechnology companies, academia, contract research organizations, and other research markets; shelf-life testing services and equipment; and COVID-19 antigen PCR testing services. It also manufactures library clones, direct to consumer home test kits, and blood and tissue serological products; and provides employee testing solutions and venue testing. In addition, the company offers controlled environment storage services and diagnostic and genomic services and products. Sourcebio International Plc was founded in 1999 and is headquartered in Nottingham, the United Kingdom.

Key Stats

• Today's Range: N/A
• 50-Day Range: 115 to 115
• 52-Week Range: N/A
• Volume: 1.57 million shs
• Average Volume: 152,444 shs
• Market Capitalization: £85.31 million
• P/E Ratio: 1,277.78
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

SBI Stock Analysis - Frequently Asked Questions

How do I buy shares of Sourcebio International?

Shares of SBI stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.

What other stocks do shareholders of Sourcebio International own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Sourcebio International investors own include boohoo group (BOO) and Mitie Group (MTO).

Industry, Sector and Symbol

• Stock Exchange: LON
• Sector: Medical
• Industry: Medical Care Facilities
• Sub-Industry: Misc.
• Current Symbol: LON:SBI
• CIK: N/A
• Web: www.sourcebioscience.com
• Phone: 44 11 5973 9012
• Fax: N/A
• Employees: 194
• Year Founded: N/A

Profitability

• EPS (Most Recent Fiscal Year): N/A
• Trailing P/E Ratio: 1,277.78
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: 35.10
• Current Ratio: 1.91
• Quick Ratio: 1.78

Sales & Book Value

• Annual Sales: £75.61 million
• Price / Sales: 0.00
• Cash Flow: N/A
• Price / Cash Flow: 5.40
• Book Value: GBX 61.90 per share
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: 74,183,000
• Free Float: N/A
• Market Cap: £85.31 million
• Optionable: Not Optionable
• Beta: N/A